Anticoagulant therapy after retinal vein occlusion in patients with protein S deficiency (Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Vol. 42[4]).
Rehak
Matus
M
Krcova
Vera
V
Slavik
Ludek
L
Müller
Marc
M
Rehak
Jiri
J
D020016:Activated Protein C Resistance / Q000150:complications; D000925:Anticoagulants / Q000627:therapeutic use*; D005165:Factor V / Q000235:genetics*; D005451:Fluorescein Angiography; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D017354:Point Mutation; D018455:Protein S Deficiency / Q000150:complications* / Q000188:drug therapy; D012170:Retinal Vein Occlusion / Q000188:drug therapy / Q000209:etiology*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V; D006493:Heparin